Laurus Labs Awaits U.S. FDA Inspection Next Month, CEO Says
2022-02-26
4
Please enable JavaScript to view the
comments powered by Disqus.
Videos similaires
Laurus Labs' Q2 Report Card & H2 Guidance: Talking Point
Q2 Review: Laurus Labs Founder & CEO On Earnings & Growth Targets
Laurus Labs In Focus | Ask Profit | NDTV Profit
Q1 Review | Laurus Labs' Founder Shares Earnings Insights
Q3 Review| Laurus Labs Growth Strategies For Coming Quarters
Q2 Review: Laurus Labs' Profit Nosedives 84% In Second Quarter
Laurus Labs Forays Into Biotech Segment Via Acquisition
Stocks In Focus: ITI, Laurus Labs, L&T, JSW Steel & More | BQ Prime
Margins Lower On R&D Spends: Laurus Labs
Laurus Labs' Management Shares Outlook For Q4 & Beyond
